Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial

BACKGROUND: Glaucoma is a major cause of sight loss worldwide, with the highest regional prevalence and incidence reported in Africa. The most common low-cost treatment used to control glaucoma is long-term timolol eye drops. However, low adherence is a major challenge. We aimed to investigate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Philippin, Heiko, Matayan, Einoti, Knoll, Karin M, Macha, Edith, Mbishi, Sia, Makupa, Andrew, Matsinhe, Cristóvão, da Gama, Vasco, Monjane, Mario, Ncheda, Awum Joyce, Mulobuana, Francisco Alcides, Muna, Elisante, Fopoussi, Nelly, Gazzard, Gus, Marques, Ana Patricia, Shah, Peter, Macleod, David, Makupa, William U, Burton, Matthew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526362/
https://www.ncbi.nlm.nih.gov/pubmed/34655547
http://dx.doi.org/10.1016/S2214-109X(21)00348-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526362/
https://www.ncbi.nlm.nih.gov/pubmed/34655547
http://dx.doi.org/10.1016/S2214-109X(21)00348-X

Ejemplares similares